Esquinas, Cristina
Ramon, Maria A.
Nuñez, Alexa
Molina, Jesús
Quintano, José A.
Roman-Rodríguez, Miguel
Naberan, Karlos
Llor, Carl
Roncero, Carlos
Miravitlles, Marc
Barrecheguren, Miriam
Article History
Accepted: 18 October 2019
First Online: 31 October 2019
Compliance with ethical standards
:
: Marc Miravitlles has received speaker or consulting fees from (in alphabetical order) AstraZeneca, Bial, Boehringer Ingelheim, Chiesi, Cipla, CSL Behring, Laboratorios Esteve, Gebro Pharma, GlaxoSmithKline, Grifols, Menarini, Mereo Biopharma, Novartis, pH Pharma, Rovi, TEVA, Verona Pharma and Zambon, and research grants from GlaxoSmithKline and Grifols, unrelated to this manuscript. The other authors have no conflicts of interest to disclose.
: All procedures performed in this study are in accordance with ethical standards of the Institutional Review Board and with the Declaration of Helsinki. All participants within their respective cohorts gave their informed written consent to participate in the original study, and each study was approved by the Research and Ethics Committee of the Hospital Clinic (Barcelona, Spain).